A Further Spotlight on OpRegen – A RPE Transplant for Dry AMD with GA

Time: 11:00 am
day: Track 2 Day 2 AM


  • Reiterative how a transplant of RPE cells can be both robust and endured by patients with dry-AMD
  • Understand further the benefits of OpRegen RPE cells in specific patients with dry-AMD, as well as primary indication of RPE-photoreceptor complex regeneration (GA reduction)
  • Evaluate how RPE cell suspensions can be reasonably scaled to marketable quantities